Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

19.5 Pathways to DollarLand

It only takes one or two to get us there
Working on 7 ADF opiods concurrently
$40 million dollars more in revenues gets us there

1.) First ever generic ER ADF labeled Oxycodone ELI-201
2.) First ever generic Embeda®
3.) First ever generic Troxyca® waiting on comparator product
4.) A $50 million dollar ANDA
5.) Approval of First ever Abuse Deterrent generic (reformulate OxyContin® )
To be filed with FDA THIS quarter
6.) File Huge Blockbuster Undisclosed NDA
7.) Lauch All four SunGen generics ($3 Billion combined markets)
8.) Buyout/Acquisition
9.)BP Partnership for entire ADF line
10.)Uplisting to NASDAQ exchange 2018-19
11.) First ever ER opiod with out food restrictions
12.) Complete PH III trials for the first ever 24 hour
13.) Generic of Reformulated Opana ® ER
14.) First ADF opiod for Chinese Pain Market by PuraCap/Humanwell
15.) Canadian Approval of SequestOx ® - patents in place
16.) FDA accepts citizen petition urging the FDA to phase out oral prescription opioid analgesics that lack abuse-deterrent properties
17.) First ever Immediate Release ADF labeled opiod with ORAL AD Labeling on hold till FDA guidance received
18.) Launch an additional 4 SunGen generics
19.) Chinese approval of SequestOx ®